Sucampo Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Sucampo Pharma (SCMP) Tops Q2 EPS by 1c; Reiterates 2017 Guidance
August 2, 2017 6:34 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $59.9 million versus the consensus estimate of $56.43 million.
Guidance
Sucampo today reiterated its guidance for the full year ending December 31, 2017. Sucampo... More
